BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Clin Pediatr. Jun 9, 2026; 15(2): 114189
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.114189
Table 1 TRPM4 variants electrophysiologically studied
Substitution
Variant
Location
Effect
Underlying mechanism
Protein expression level on membrane
Current density
Ca2+ dependence
Voltage-dependence
Electrophysiological results
Classification
ECG morphology; phenotype
Ref.
p.E7Kc.19G>AN-terminus. Putative CaM binding siteGoFImpaired SUMOylation (attenuated deSUMOylation). Impaired endocytosis
Enhanced interaction of PIP2 and TRPM4 protein (increased risk of generating triggered activities)
Prolonged AP (due to facilitated open state condition). Depolarizing shifts of the resting membrane potential (depending on the channel density or maximal activity). Insensitivityto PIP2 depletionPathogenicPFHB1B, RBBB, progressive conduction block[30,49]
p. R164Wc.490C>TN-terminusGoFNo changesNo changesNo effect on SUMOylation stimulation. Dynamitin-insensitivePathogenicPFHB1B[48]
p.D198GPutative CaM binding siteNo changesNo changesUncertain significance[50,51]
p.A432Tc.1294G>AN-terminusGoFLikely to be caused by protein misfolding and retention in the endoplasmic reticulum No changesCotransfection experiments of TRPM4 mutants with Ubc9 showed an increase of current density (stimulating effect on SUMOylation). Dynamitin-insensitive. Lowering the incubation temperature of cells expressing the variant to 28 °C for 24 hours increased their expression both at the total level (A432T 78% ± 3% of WT); and at the cell surface level (A432T 72% ± 8% of WT). A significant increase in the current density of A432T was observed (599 ± 104 pA/pF at 28 °C vs 230 ± 27 pA/pF at 37 °C), whereas WT showed no significant change (639 ± 101 pA/pF at 28 °C vs 553 ± 74 pA/pF at 37 °C;P > 0.05) PathogenicPFHB1A. PFHB1B. Atrioventricular block. Brugada syndrome[49]
p.A432T/G582S N-terminusLoFLikely to be caused by protein misfolding and retention in the endoplasmic reticulum No changesLowering the incubation temperature of cells expressing the variant to 28 °C for 24 hours increased their expression both at the total level (A432T/G582S 69% ± 5% of WT) and at the cell surface level (A432T/G582S 65% ± 7% of WT)
p.V441MLoF[49]
p.R499WLoF[48]
p.G582Sc.1744G>AN-terminusGoFDirect SUMOylation of TRPM4 is unlikely to be linked to the increased expression and gain of function of the variant↑ (171% ± 20% of WT)PathogenicPFHB1A. PFHB1B. Brugada syndrome[48]
p.T677IN-terminusNo changesNo changesUncertain significance
p. P779Rc.2336C>GTM2V1/2 ↑Uncertain significanceBrugada syndrome. Right bundle brunch block
p.G844Dc.2531G>AABC-motifGoFNo changesNo changesCotransfection experiments of TRPM4 mutants with Ubc9 showed an increase of current density (stimulating effect on SUMOylation). Dynamitin-insensitivePathogenicPFHB1B right bundle-branch block. Brugada syndrome. Long QT syndrome[48]
p.T873Ic.2618C>TTM3No changesUncertain significance[48]
p.K914Xc.2740A>TPutative SUMOylation siteNon-functional channelNo currentNo changesLikely benignPFHB1B right bundle-branch block[52]
p.V921Ic.2761G>ATM4-TM5 No changesNo significant changesLikely benignPFHB1B[49,53]
p.L1075Pc.3224T>CC-terminusNo changes
Uncertain significancePFHB1B
Table 2 Genetic variants identified in patients
Patients
Gene
GRCh38
Nucleotide change
Amino acid change
db SNP, MAF%
CADD
SIFTcat
PolyPhenCat
Patient 1TRPM4Chr19:49200722, NM 017636.4: C.C2890Ap.Arg964Serrs749078579, 0.001592%26DeleteriousPD
Patient 2TRPM4Chr19:49210799NM 017636.4: C.A3418Tp.Lys1140TerNo data45NANA
Patient 2MYPNChr10: 68201958 NM 032578.4: C.A3623Tp.Asp1208ValNo data32DeleteriousPD


Write to the Help Desk